Answers are grounded in this paper and cite their sources.
Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disorder characterized by sustained intestinal inflammation, disruption of epithelial barrier function, and dysregulation of immune responses. Potassium poly-γ-glutamate (PGA-K) is a natural biopolymer produced by Bacillus subtilis chungkookjang and is known for its immunomodulatory properties. In this study, we evaluated the preventive potential of PGA-K as a bioactive food-derived ingredient against intestinal inflammation. In an in vitro LPS-stimulated macrophages, PGA-K significantly inhibited TNF-α secretion and reduced NO production, with the most pronounced effect observed at the highest tested concentration. In a dextran sulfate sodium (DSS)-induced colitis mouse model, prophylactic oral administration of PGA-K attenuated colitis-associated parameters, including body weight loss, disease activity index (DAI), and colon shortening. PGA-K also reduced inflammatory cytokine levels in colon tissue, and histological analysis revealed preservation of colonic mucosal architecture with reduced inflammatory cell infiltration. PGA-K administration was associated with modest microbiota changes under DSS-induced conditions, although these did not remain significant after multiple-comparison correction. These findings suggest that PGA-K, as a natural food-derived bioactive ingredient, holds preventive potential for supporting intestinal immune homeostasis under inflammatory conditions.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: